This has led to the hope that similar products may be developed for hMPV, and Moderna has recently started trials into a mRNA hMPV vaccine. There are no treatments that have been clearly ...

While there are currently no vaccines for HMPV, Moderna, who also produced COVID-19 vaccines, is scheduled to make one.

‘Moderna started clinical trials in 2017 ... the company initiated clinical trials of mRNA vaccine candidates against CMV, human metapneumovirus and parainfluenza as well as therapeutics against ...

Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...

A big reason for this pressure is the spread of viruses including the human metapneumovirus (HMPV), which has seen a sharp increase in Wales during the first week of January. The virus is causing ...

People in the UK have been advised to avoid some medical settings and to wear masks in some hospitals and clinics after a rise in cases of a virus now as HMPV. Infections caused concern when there ...

Human metapneumovirus (HMPV), although discovered in 2001, is making headlines after an unspecified increase in cases was reported in China. Although it has not been officially pronounced by local ...

Moderna, Inc. (NASDAQ:MRNA – Get Free Report) saw unusually large options trading activity on Thursday. Stock investors purchased 143,752 call options on the company. This represents an increase of ...

hVIVO plc (AIM: HVO), a fast-growing early-stage Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that, following the success of its pilot human ...

First reported in children from the Netherlands in 2001. Retrospective studies have shown the presence of human metapneumovirus (HMPV) in the human population from as early as the 1950s.